Small nucleolar RNA-derived microRNA hsa-miR-1291 modulates cellular drug disposition through direct targeting of ABC transporter ABCC1

Drug Metabolism and Disposition

Volumn 41, Issue 10, 2013, Pages 1744-1751

  Pan, Yu Zhuo ^a   Zhou, Amy ^a   Hu, Zihua ^a   Yu, Ai Ming ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR; DOXORUBICIN; LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 1291; MULTIDRUG RESISTANCE PROTEIN 1; PLASMID VECTOR; SMALL NUCLEOLAR RNA; SNORA34 PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BIOINFORMATICS; CANCER CELL CULTURE; CHEMOSENSITIVITY; CONTROLLED STUDY; DOWN REGULATION; DRUG ACCUMULATION; DRUG DISPOSITION; DRUG SENSITIZATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NUCLEOTIDE SEQUENCE; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN TARGETING; REPORTER GENE;

3' UNTRANSLATED REGIONS; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HEK293 CELLS; HUMANS; MICRORNAS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; RNA, MESSENGER; RNA, SMALL NUCLEOLAR; XENOBIOTICS;

EID: 84884696854     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.113.052092     Document Type: Article

References (44)

1. Borel F, Han R, Visser A, Petry H, van Deventer SJ, Jansen PL, and Konstantinova P; Réseau Centre de Ressources Biologiques Foie (French Liver Biobanks Network), France (2012) Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs. Hepatology 55:821-832.
2. Brameier M, Herwig A, Reinhardt R, Walter L, and Gruber J (2011) Human box C/D snoRNAs with miRNA like functions: expanding the range of regulatory RNAs. Nucleic Acids Res 39: 675-686.
3. Cho S, Lu M, He X, Ee PL, Bhat U, Schneider E, Miele L, and Beck WT (2011) Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cells. Proc Natl Acad Sci USA 108:20778-20783.
4. Darzacq X, Jády BE, Verheggen C, Kiss AM, Bertrand E, and Kiss T (2002) Cajal body-specific small nuclear RNAs: a novel class of 2′-O-methylation and pseudouridylation guide RNAs. EMBO J 21:2746-2756. (Pubitemid 34619390)
5. Ender C, Krek A, Friedländer MR, Beitzinger M, Weinmann L, Chen W, Pfeffer S, Rajewsky N, and Meister G (2008) A human snoRNA with microRNA-like functions. Mol Cell 32: 519-528.
6. Faggad A, Darb-Esfahani S, Wirtz R, Sinn B, Sehouli J, Könsgen D, Lage H, Noske A, Weichert W, and Buckendahl AC, et al. (2009) Expression of multidrug resistance-associated protein 1 in invasive ovarian carcinoma: implication for prognosis. Histopathology 54:657-666.
7. Filipits M, Pohl G, Rudas M, Dietze O, Lax S, Grill R, Pirker R, Zielinski CC, Hausmaninger H, and Kubista E, et al. (2005) Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group. J Clin Oncol 23:1161-1168. (Pubitemid 46202272)
8. Gomez A and Ingelman-Sundberg M (2009) Pharmacoepigenetics: its role in interindividual differences in drug response. Clin Pharmacol Ther 85:426-430.
9. Guo L, Liu Y, Bai Y, Sun Y, Xiao F, and Guo Y (2010) Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis. Eur J Cancer 46:1692-1702.
10. Haber M, Smith J, Bordow SB, Flemming C, Cohn SL, London WB, Marshall GM, and Norris MD (2006) Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma. J Clin Oncol 24:1546-1553. (Pubitemid 46638777)
11. Haenisch S, Laechelt S, Bruckmueller H, Werk A, Noack A, Bruhn O, Remmler C, and Cascorbi I (2011) Down-regulation of ATP-binding cassette C2 protein expression in HepG2 cells after rifampicin treatment is mediated by microRNA-379. Mol Pharmacol 80:314-320.
12. Hidaka H, Seki N, Yoshino H, Yamasaki T, Yamada Y, Nohata N, Fuse M, Nakagawa M, and Enokida H (2012) Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma. Oncotarget 3: 44-57.
13. Hill CR, Jamieson D, Thomas HD, Brown CD, Boddy AV, and Veal GJ (2013) Characterisation of the roles of ABCB1, ABCC1, ABCC2 and ABCG2 in the transport and pharmacokinetics of actinomycin D in vitro and in vivo. Biochem Pharmacol 85:29-37.
14. Ingelman-Sundberg M and Gomez A (2010) The past, present and future of pharmacoepigenomics. Pharmacogenomics 11:625-627.
15. Kasinski AL and Slack FJ (2011) Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 11: 849-864.
16. Kiss AM, Jády BE, Bertrand E, and Kiss T (2004) Human box H/ACA pseudouridylation guide RNA machinery. Mol Cell Biol 24:5797-5807. (Pubitemid 38787965)
17. Kiss AM, Jády BE, Darzacq X, Verheggen C, Bertrand E, and Kiss T (2002) A Cajal body-specific pseudouridylation guide RNA is composed of two box H/ACA snoRNA-like domains. Nucleic Acids Res 30:4643-4649. (Pubitemid 35331745)
18. Kiss T (2002) Small nucleolar RNAs: an abundant group of noncoding RNAs with diverse cellular functions. Cell 109:145-148.
19. Kovalchuk O, Filkowski J, Meservy J, Ilnytskyy Y, Tryndyak VP, Chekhun VF, and Pogribny IP (2008) Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther 7:2152-2159.
20. Kung JT, Colognori D, and Lee JT (2013) Long noncoding RNAs: past, present, and future. Genetics 193:651-669.
21. Li X, Pan YZ, Seigel GM, Hu ZH, Huang M, and Yu AM (2011) Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cells. Biochem Pharmacol 81:783-792.
22. Liang Z, Wu H, Xia J, Li Y, Zhang Y, Huang K, Wagar N, Yoon Y, Cho HT, and Scala S, et al. (2010) Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem Pharmacol 79: 817-824.
23. Maeno K, Nakajima A, Conseil G, Rothnie A, Deeley RG, and Cole SP (2009) Molecular basis for reduced estrone sulfate transport and altered modulator sensitivity of transmembrane helix (TM) 6 and TM17 mutants of multidrug resistance protein 1 (ABCC1). Drug Metab Dispos 37: 1411-1420.
24. Maroney PA, Chamnongpol S, Souret F, and Nilsen TW (2008) Direct detection of small RNAs using splinted ligation. Nat Protoc 3:279-287. (Pubitemid 351266512)
25. Meder B, Keller A, Vogel B, Haas J, Sedaghat-Hamedani F, Kayvanpour E, Just S, Borries A, Rudloff J, and Leidinger P, et al. (2011) MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic Res Cardiol 106:13-23.
26. Mohri T, Nakajima M, Fukami T, Takamiya M, Aoki Y, and Yokoi T (2010) Human CYP2E1 is regulated by miR-378. Biochem Pharmacol 79:1045-1052.
27. Morin RD, O'Connor MD, Griffith M, Kuchenbauer F, Delaney A, Prabhu AL, Zhao Y, McDonald H, Zeng T, and Hirst M, et al. (2008) Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res 18: 610-621. (Pubitemid 351482785)
28. Nakajima M and Yokoi T (2011) MicroRNAs from biology to future pharmacotherapy: regulation of cytochrome P450s and nuclear receptors. Pharmacol Ther 131:330-337.
29. Pajic M, Murray J, Marshall GM, Cole SP, Norris MD, and Haber M (2011) ABCC1 G2012T single nucleotide polymorphism is associated with patient outcome in primary neuroblastoma and altered stability of the ABCC1 gene transcript. Pharmacogenet Genomics 21:270-279.
30. Pan YZ, Gao W, and Yu AM (2009a) MicroRNAs regulate CYP3A4 expression via direct and indirect targeting. Drug Metab Dispos 37:2112-2117.
31. Pan YZ, Morris ME, and Yu AM (2009b) MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells. Mol Pharmacol 75: 1374-1379.
32. Rodrigues AC, Li X, Radecki L, Pan YZ, Winter JC, Huang M, and Yu AM (2011) MicroRNA expression is differentially altered by xenobiotic drugs in different human cell lines. Biopharm Drug Dispos 32:355-367.
33. Saraiya AA and Wang CC (2008) snoRNA, a novel precursor of microRNA in Giardia lamblia. PLoS Pathog 4:e1000224.
34. Scott MS, Avolio F, Ono M, Lamond AI, and Barton GJ (2009) Human miRNA precursors with box H/ACA snoRNA features. PLOS Comput Biol 5:e1000507.
35. To KK, Zhan Z, Litman T, and Bates SE (2008) Regulation of ABCG2 expression at the 3′ untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line. Mol Cell Biol 28:5147 -5161.
36. Triller N, Korosec P, Kern I, Kosnik M, and Debeljak A (2006) Multidrug resistance in small cell lung cancer: expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease. Lung Cancer 54:235-240. (Pubitemid 44764911)
37. Tsuchiya Y, Nakajima M, Takagi S, Taniya T, and Yokoi T (2006) MicroRNA regulates the expression of human cytochrome P450 1B1. Cancer Res 66:9090-9098. (Pubitemid 44521128)
38. Wang F, Xue X, Wei J, An Y, Yao J, Cai H, Wu J, Dai C, Qian Z, and Xu Z, et al. (2010) hsa-miR- 520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations. Br J Cancer 103:567-574.
39. Wang KC and Chang HY (2011) Molecular mechanisms of long noncoding RNAs. Mol Cell 43:904-914.
40. Watkins NJ and Bohnsack MT (2012) The box C/D and H/ACA snoRNPs: key players in the modification, processing and the dynamic folding of ribosomal RNA. Wiley Interdiscip Rev RNA 3:397-414.
41. Yokoi T and Nakajima M (2013) microRNAs as mediators of drug toxicity. Annu Rev Pharmacol Toxicol 53:377-400.
42. Yu AM (2009) Role of microRNAs in the regulation of drug metabolism and disposition. Expert Opin Drug Metab Toxicol 5:1513-1528.
43. Yu AM and Pan YZ (2012) Noncoding microRNAs: Small RNAs play a big role in regulation of ADME? Acta Pharmaceutica Sinica B 2:93-101.
44. Zhu H, Wu H, Liu X, Evans BR, Medina DJ, Liu CG, and Yang JM (2008) Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 76:582-588.